|
AHI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.789700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.666350E-02 |
| Normal-vs-Stage2 |
8.104100E-03 |
| Normal-vs-Stage3 |
1.227580E-04 |
| Normal-vs-Stage4 |
5.795200E-03 |
| Stage1-vs-Stage2 |
2.096800E-01 |
| Stage1-vs-Stage3 |
4.986300E-02 |
| Stage1-vs-Stage4 |
3.166200E-01 |
| Stage2-vs-Stage3 |
8.881000E-01 |
| Stage2-vs-Stage4 |
7.997000E-01 |
| Stage3-vs-Stage4 |
6.341000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.177190E-03 |
| Normal-vs-AfricanAmerican |
7.616800E-01 |
| Normal-vs-Asian |
1.454840E-01 |
| Caucasian-vs-AfricanAmerican |
1.697990E-01 |
| Caucasian-vs-Asian |
2.140000E-01 |
| AfricanAmerican-vs-Asian |
5.892600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.995270E-04 |
| Normal-vs-Female |
5.775300E-03 |
| Male-vs-Female |
4.748500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.794100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.183000E-03 |
| Normal-vs-Age(61-80Yrs) |
8.18730000000656E-05 |
| Normal-vs-Age(81-100Yrs) |
2.441000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.833000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.214290E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.161760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.094190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.386800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.488200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.861100E-03 |
| Classical-VS-Follicular |
7.98069999999873E-05 |
| Classical-VS-Other |
3.721800E-01 |
| Classical-VS-Normal |
1.096220E-01 |
| Tall-VS-Follicular |
8.822600E-01 |
| Tall-VS-Other |
5.706600E-01 |
| Tall-VS-Normal |
1.240070E-04 |
| Follicular-VS-Other |
6.862000E-01 |
| Follicular-VS-Normal |
3.70840000000205E-05 |
| Other-VS-Normal |
9.686100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.70340000000314E-05 |
| Normal-vs-N1 |
1.988380E-01 |
| N0-vs-N1 |
9.957700E-02 |
|
|
